06:04:39South Africa

CV Sciences, Inc. (CVSI)

OTC Markets

Key stats Fiscal year 2025

Income statement

Revenue
13,789,000 -12.2%
Net income
-958,000
Gross profit
6,752,000
Operating income
-470,000
Earnings per share
-0.01
R&D expense
122,000

Growth and profitability

Gross margin
48.97
Operating margin
-3.41
Net margin
-6.95
Return on equity
-65.26
Return on assets
-13.76
Free cash flow margin
-3.74

Balance sheet

Total assets
6,962,000
Total liabilities
5,494,000
Shareholders' equity
1,468,000
Cash and equivalents
278,000
Debt
1,649,000
Net debt
1,371,000
Current ratio
1.03
Debt to equity
1.12

Cash flow and ratios

Operating cash flow
-407,000
Free cash flow
-516,000

Shareholder returns

Shares outstanding
242,184,128
Book value per share
0.01
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
San Diego, CA
Exchange
OTC Markets
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

CV Sciences, Inc. trades on OTC Markets under the ticker symbol CVSI. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis